CN109589304A — 利培酮口服溶液及其制备方法
Assigned to BEIJING D-VENTUREPHARM TECHNOLOGY DEVELOPMENT Co Ltd · Expires 2019-04-09 · 7y expired
What this patent protects
本发明属药物制剂领域,涉及一种利培酮口服液体制剂。本发明以利培酮为有效成分,添加适宜的辅料如pH缓冲剂、矫味剂、甜味剂、防腐剂等,采用溶液制剂制备工艺配制成无色澄清透明的液体制剂。本发明的利培酮口服液体制剂,药物以分子状态分散在介质中,吸收速度快,能快速发挥药效,服用方便,易于分剂量,能同时满足临床用药、患者顺应性、工业化规模生产等各项要求。
USPTO Abstract
本发明属药物制剂领域,涉及一种利培酮口服液体制剂。本发明以利培酮为有效成分,添加适宜的辅料如pH缓冲剂、矫味剂、甜味剂、防腐剂等,采用溶液制剂制备工艺配制成无色澄清透明的液体制剂。本发明的利培酮口服液体制剂,药物以分子状态分散在介质中,吸收速度快,能快速发挥药效,服用方便,易于分剂量,能同时满足临床用药、患者顺应性、工业化规模生产等各项要求。
Drugs covered by this patent
- Risperdal (risperidone) · Johnson & Johnson (Janssen)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.